[A resected case of advanced gastric cancer with multiple liver metastasis successfully treated by preoperative and postoperative S-1/CPT-11 combination chemotherapy]. 2011

Kotaro Matsumoto, and Takashi Morisaki, and Tatsuya Hirano, and Masayuki Sada
Dept. of Surgery, Hamanamachi Hospital.

A 75-year-old man was admitted for anemia, and a tar stool found by endoscopic examination revealed a type 3 advanced gastric cancer in the lower stomach. Multiple liver metastases 4 cm in diameter were shown on CT. Because we thought that the case was unresectable, S-1/CPT-11 chemotherapy was performed. S-1 (80mg/body/day) was orally administered for 2 weeks followed by a drug-free 1 week, and CPT-11 (100mg/body/day) was given intravenously on days 1 and 8. After 3 courses of chemotherapy, the primary lesion, the regional lymph nodes, and the metastatic lesion of the liver were slightly reduced in size. He was judged as clinical PR, and distal gastrectomy and lymph node dissection were performed. One month after surgery the tumor marker values became normal, and CT could hardly detect metastatic liver tumors. Now, after 3 years, the PR stage has been maintained. Combined use of peroral S-1 and CPT-11 by intravenous infusion is effective for multiple liver metastasis after gastrectomy in gastric cancer.

UI MeSH Term Description Entries
D008113 Liver Neoplasms Tumors or cancer of the LIVER. Cancer of Liver,Hepatic Cancer,Liver Cancer,Cancer of the Liver,Cancer, Hepatocellular,Hepatic Neoplasms,Hepatocellular Cancer,Neoplasms, Hepatic,Neoplasms, Liver,Cancer, Hepatic,Cancer, Liver,Cancers, Hepatic,Cancers, Hepatocellular,Cancers, Liver,Hepatic Cancers,Hepatic Neoplasm,Hepatocellular Cancers,Liver Cancers,Liver Neoplasm,Neoplasm, Hepatic,Neoplasm, Liver
D008197 Lymph Node Excision Surgical excision of one or more lymph nodes. Its most common use is in cancer surgery. (From Dorland, 28th ed, p966) Lymph Node Dissection,Lymphadenectomy,Dissection, Lymph Node,Dissections, Lymph Node,Excision, Lymph Node,Excisions, Lymph Node,Lymph Node Dissections,Lymph Node Excisions,Lymphadenectomies,Node Dissection, Lymph,Node Dissections, Lymph
D008297 Male Males
D010094 Oxonic Acid Antagonist of urate oxidase. Oteracil
D012074 Remission Induction Therapeutic act or process that initiates a response to a complete or partial remission level. Induction of Remission,Induction, Remission,Inductions, Remission,Remission Inductions
D002166 Camptothecin An alkaloid isolated from the stem wood of the Chinese tree, Camptotheca acuminata. This compound selectively inhibits the nuclear enzyme DNA TOPOISOMERASES, TYPE I. Several semisynthetic analogs of camptothecin have demonstrated antitumor activity. Camptothecine
D003131 Combined Modality Therapy The treatment of a disease or condition by several different means simultaneously or sequentially. Chemoimmunotherapy, RADIOIMMUNOTHERAPY, chemoradiotherapy, cryochemotherapy, and SALVAGE THERAPY are seen most frequently, but their combinations with each other and surgery are also used. Multimodal Treatment,Therapy, Combined Modality,Combined Modality Therapies,Modality Therapies, Combined,Modality Therapy, Combined,Multimodal Treatments,Therapies, Combined Modality,Treatment, Multimodal,Treatments, Multimodal
D004338 Drug Combinations Single preparations containing two or more active agents, for the purpose of their concurrent administration as a fixed dose mixture. Drug Combination,Combination, Drug,Combinations, Drug
D005641 Tegafur Congener of FLUOROURACIL with comparable antineoplastic action. It has been suggested especially for the treatment of breast neoplasms. 1-(2-Tetrahydrofuryl)-5-fluorouracil,1-(Tetrahydro-2-furanyl)-5-fluorouracil,5-Fluoro-1-(tetrahydro-2-furanyl)-2,4-pyrimidinedione,FT-207,FT207,Florafur,Fluorofur,Ftorafur,Futraful,N1-(2'-Tetrahydrofuryl)-5-fluorouracil,Sunfural S,Uftoral,Utefos,FT 207
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

Kotaro Matsumoto, and Takashi Morisaki, and Tatsuya Hirano, and Masayuki Sada
November 2007, Gan to kagaku ryoho. Cancer & chemotherapy,
Kotaro Matsumoto, and Takashi Morisaki, and Tatsuya Hirano, and Masayuki Sada
July 2010, Gan to kagaku ryoho. Cancer & chemotherapy,
Kotaro Matsumoto, and Takashi Morisaki, and Tatsuya Hirano, and Masayuki Sada
November 2016, Gan to kagaku ryoho. Cancer & chemotherapy,
Kotaro Matsumoto, and Takashi Morisaki, and Tatsuya Hirano, and Masayuki Sada
October 2009, Gan to kagaku ryoho. Cancer & chemotherapy,
Kotaro Matsumoto, and Takashi Morisaki, and Tatsuya Hirano, and Masayuki Sada
November 2011, Gan to kagaku ryoho. Cancer & chemotherapy,
Kotaro Matsumoto, and Takashi Morisaki, and Tatsuya Hirano, and Masayuki Sada
November 2009, Gan to kagaku ryoho. Cancer & chemotherapy,
Kotaro Matsumoto, and Takashi Morisaki, and Tatsuya Hirano, and Masayuki Sada
November 2009, Gan to kagaku ryoho. Cancer & chemotherapy,
Kotaro Matsumoto, and Takashi Morisaki, and Tatsuya Hirano, and Masayuki Sada
October 2006, Gan to kagaku ryoho. Cancer & chemotherapy,
Kotaro Matsumoto, and Takashi Morisaki, and Tatsuya Hirano, and Masayuki Sada
March 1999, Gan to kagaku ryoho. Cancer & chemotherapy,
Kotaro Matsumoto, and Takashi Morisaki, and Tatsuya Hirano, and Masayuki Sada
September 2008, Gan to kagaku ryoho. Cancer & chemotherapy,
Copied contents to your clipboard!